Fertility Supplement Market: Current Analysis and Forecast (2022-2028)

Global Fertility Supplement Market is expected to grow at a significant rate of around 7.8% during the forecast period. Fertility supplement contains nutrients, such as folic acid, fish oil, selenium, vitamin E, vitamin D, and others to enhance the fertility of the individuals. Surge in the prevalence of infertility globally and rising rates of obesity are the key drivers boosting the growth of the market. For instance, according to the World Health Organization, in 2021, there were around 48 million couples, and 186 million individuals suffering from infertility disease globally. Apart from this, an increase in disposable income and the high adoption of a sedentary lifestyle is also having a positive impact on the market during the forecast period.

Fairhaven Health; Coast Science; Lenus Pharma GesmbH; Bionova; Vitabiotics Ltd.; Orthomol; Exeltis USA, Inc.; The Bird and Be Co. Inc.; VH Nutrition LLC, and TTK HealthCare Ltd. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, tablet category to witness higher CAGR during the forecast period"

Based on product, the market is categorized into capsules, tablets, soft gels, powder, and liquids. The tablets segment is expected to grow with high CAGR rates during the forecast period. Excipients in high-quality supplements help in tablet absorption and disintegration. Although the natural coating enhances dissolution, several other factors including efficacy and quality influence absorption. These factors are expected to drive the growth of the market during the forecast period. Apart from this, the product's ease of absorption, cost-effectiveness, and disintegration are other factors propelling the growth of the market.

"Amongst end-user type, the female to hold a significant share in the market in 2020"

On the basis of end-user, the fertility supplement market is segmented into men and women. Women held the maximum share in the global market due to an increase in fertility issues among married infertile women. Moreover, companies are rapidly launching their product in the global market which is also driving the growth of the market during the forecast period. For instance, in May 2020, WellSource Nutraceuticals launched Methyl-NX to specifically address the unique design criteria to support in vitro fertilization and fertility programs. It was created to provide sufficient quantities of bioactive folate, essential B vitamins and omega-3.

"North America to hold a significant share in the market"

In 2020, North America held a significant share of the global fertility supplement market which is due to the rising population of infertile men and women. According to the data from the Centers for Disease Control and Prevention (CDC), in 2017, around 6 million women which are estimated to be around 10% of the US women population have difficulty in conceiving a child. Additionally, in the US, there were more than 15 out of every 100 adults aging 18 or more smoke, according to the CDC. Similarly, the healthcare expenditure of the U.S. is high which is another factor driving the market's growth.